According to Global Blue Group's latest financial reports the company has a price-to-book ratio of 12.5.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 11.9 | -93.85% |
2022-12-31 | 194 | -3284.67% |
2021-12-31 | -6.08 | -73.24% |
2020-12-31 | -22.7 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 5.12 | -59.20% | ๐บ๐ธ USA |
Medtronic MDT | 2.04 | -83.77% | ๐ฎ๐ช Ireland |
Boston Scientific BSX | 5.51 | -56.10% | ๐บ๐ธ USA |
Edwards Lifesciences EW | 7.76 | -38.16% | ๐บ๐ธ USA |
Stryker Corporation SYK | 6.87 | -45.30% | ๐บ๐ธ USA |